A5103042496- Heart Failure Treatment and Management
- Esophageal Cancer Research and Treatment
- Chronic Disease Management Strategies
- Esophageal and GI Pathology
- Dialysis and Renal Disease Management
- Radiomics and Machine Learning in Medical Imaging
- Gastric Cancer Management and Outcomes
- Cardiovascular Function and Risk Factors
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Global Cancer Incidence and Screening
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- Chronic Kidney Disease and Diabetes
- Immunotherapy and Immune Responses
- Cancer, Lipids, and Metabolism
- Metabolism, Diabetes, and Cancer
University of Azad Jammu and Kashmir
2025
Dow University of Health Sciences
2022-2024
Kidney failure ranks as the tenth leading cause of mortality in United States (US), frequently arising a complication associated with diabetes mellitus (DM).
e23258 Background: Esophageal cancer (EC) is the sixth leading cause of cancer-related deaths in United States, with a mere 20% survival rate first five years, making it significant public health concern. Considering lack comprehensive evaluations mortality trends that are undergoing substantial transformations on global scale, this study aims to provide an update rates esophageal and its States. Methods: The among adults EC were analyzed using data from Centers for Disease Control...
Objectives: Esophageal cancer (EC) is the sixth leading cause of cancer-related deaths in United States, with a mere 20% survival rate first 5 years, making it significant public health concern. Considering lack comprehensive evaluations mortality trends, this study aims to provide an update on rates esophageal and its trends States. Methods: The among adults EC were analyzed using data from CDC WONDER database. Crude age-adjusted (AAMRs) per 100,000 people extracted. Annual percent changes...
Background:The prevalence rate of diabetes mellitus (DM) is becoming higher not only in developing countries but also worldwide. The commonly used tests for the diagnosis DM lackstandardization and sensitivity.DNA based free-circulatingbiomarkers are gaining attention as promising biomarkers diagnosis, prognosis, andprogression different diseases. In DM,β-cell destruction results release free DNA into plasmawhich can be quantified by approaches. our study, we have compared level total...